Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Clinical trial NCT04672434 · COMPLETED
Trial details
- NCT number
- NCT04672434
- Sponsor
- Symphogen A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2024-11-22
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.